Dr Reddy's Acquires MenoLabs to Expand Presence in US Women's Health Market

Dr. Reddy's has secured MenoLabs' full supplements portfolio, encompassing seven branded products addressing perimenopause and menopause symptoms. This strategic acquisition solidifies the company's ongoing commitment to women's health.

Hyderabad-based Dr Reddy's Laboratories has acquired US-based MenoLabs. The acquisition deal is a part of Dr Reddy's strategy to expand its presence in the rapidly growing women's nutritional and wellness market in the US.

Reportedly, Dr Reddy's has secured the complete MenoLabs supplements portfolio, which comprises seven branded products specifically designed to offer health support and address symptoms associated with perimenopause and menopause. However, the financial details of the deal were not disclosed.

The notable products in MenoLabs' portfolio include MenoFit and MenoGlow probiotics, Happy Fiber and Well Rested dietary supplements, Athena’s Shield menopause support supplement, and Goodness Glow and Keep Glowing Gorgeous supplements geared towards healthy ageing support.

This strategic acquisition also encompasses the MenoLife health tracker app, an integral component of the MenoLabs ecosystem, providing consumers with community, education, and information related to menopause.

Commenting on the acquisition, Marc Kikuchi, CEO, Dr Reddy’s North America, said, “The MenoLabs acquisition will serve as a catalyst to accelerate growth in this space and build upon our aspiration to lead in the fast-growing women’s nutritional and wellness markets. The acquisition complements Dr Reddy’s US self-care and wellness business portfolio of brands.

The acquisition not only marks a strategic expansion for Dr Reddy's but also positions the company as a key player in women's health and wellness, aligning with the growing trend of consumers actively seeking nutritional and wellness solutions.

This move comes at a crucial time, as the demand for women's health products continues to rise, driven by an increasing awareness of holistic well-being. Dr Reddy's Laboratories aims to leverage the existing MenoLabs brand equity and customer base to strengthen its foothold in this competitive market.

The MenoLabs product line is well-established in the US market, primarily distributed through the brand’s own website and popular e-commerce platforms such as Amazon and Walmart. With a diverse portfolio of supplements and the added value of the MenoLife app, Dr Reddy's seeks to make a significant impact on the women's health sector in the US.

Founded in 1984, Dr Reddy's is a global pharmaceutical company that offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars, and over-the-counter (OTC) products.

In another strategic move, days back, Dr Reddy's Laboratories acquired a substantial 6.5% stake in the Israeli biotech firm Edity. The transaction involved a cash consideration of $2 million, with Dr Reddy's purchasing 10,14,442 preferred A-1 shares at $1.9715 per share. This move aligns with Dr Reddy's ongoing efforts to diversify its portfolio and strengthen its global presence in the biotech sector.